Epigallocatechin-3-gallate suppressed breast oncogenesis via the miR-27a/Wnt/β-catenin pathway axis - Top-Institutions - MDSpire

Epigallocatechin-3-gallate suppressed breast oncogenesis via the miR-27a/Wnt/β-catenin pathway axis

  • By

  • Shrila Banerjee

  • Abul Kalam Azad Mandal

  • June 11, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology

  • #2

    MD Anderson’s Institute for Data Science in Oncology (IDSO)
    MD Anderson’s Institute for Data Science in Oncology (IDSO)

    Houston, Texas

    Key Differentiators

    • Oncology

  • #3

    Department of Breast Medical Oncology
    Department of Breast Medical Oncology

    Houston, Texas

    Key Differentiators

    • Oncology

  • #4

    University of Cincinnati
    University of Cincinnati

    Cincinnati, Ohio

    Key Differentiators

    • Oncology

  • #5

    Vanderbilt-Ingram Cancer Center
    Vanderbilt-Ingram Cancer Center

    Nashville, Tennessee

    Key Differentiators

    • Oncology

Original Source(s)

Epigallocatechin-3-gallate suppressed breast oncogenesis via the miR-27a/Wnt/β-catenin pathway axis

  • by Shrila Banerjee, Abul Kalam Azad Mandal

  • June 11, 2026

Related Content

Long-term results after surgical resection of intrahepatic cholangiocarcinoma before and since the BILCAP era

Global research trends and hotspots in human immunodeficiency virus-associated cervical cancer (1990–2025): a multi-database bibliometric analysis

The future of neurosurgical oncology lies in cognitive neurosciences: understanding brain processing is much more valuable than surgical technology